227 related articles for article (PubMed ID: 21343933)
1. Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse.
Lu CY; Uen YH; Tsai HL; Chuang SC; Hou MF; Wu DC; Juo SH; Lin SR; Wang JY
Br J Cancer; 2011 Mar; 104(7):1178-84. PubMed ID: 21343933
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
3. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection.
Uen YH; Lu CY; Tsai HL; Yu FJ; Huang MY; Cheng TL; Lin SR; Wang JY
Ann Surg Oncol; 2008 Aug; 15(8):2120-8. PubMed ID: 18481151
[TBL] [Abstract][Full Text] [Related]
4. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer.
Lu CY; Tsai HL; Uen YH; Hu HM; Chen CW; Cheng TL; Lin SR; Wang JY
Br J Cancer; 2013 Mar; 108(4):791-7. PubMed ID: 23422758
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance.
Wu CH; Lin SR; Hsieh JS; Chen FM; Lu CY; Yu FJ; Cheng TL; Huang TJ; Huang SY; Wang JY
Dis Markers; 2006; 22(3):103-9. PubMed ID: 16788243
[TBL] [Abstract][Full Text] [Related]
9. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
[TBL] [Abstract][Full Text] [Related]
10. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
13. Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer.
Murono K; Kazama S; Yamaguchi H; Kawai K; Ishihara S; Sunami E; Kitayama J; Satoh Y; Kurihara M; Yatomi Y; Watanabe T
Surgery; 2015 Feb; 157(2):322-30. PubMed ID: 25311262
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
15. Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels.
Wang JY; Lin SR; Wu DC; Lu CY; Yu FJ; Hsieh JS; Cheng TL; Koay LB; Uen YH
Clin Cancer Res; 2007 Apr; 13(8):2406-13. PubMed ID: 17406027
[TBL] [Abstract][Full Text] [Related]
16. Implications of Pretreatment Serum Carcinoembryonic Antigen Levels and Perineural Invasion with Staging, Prognosis, and Management in Stage I-III Colon Cancer after Surgery: A Retrospective Cohort Study in the SEER Database.
Zhang Q; Wang L; Sun R; Gao J; Liu T
Ann Ital Chir; 2024; 95(2):144-154. PubMed ID: 38684496
[TBL] [Abstract][Full Text] [Related]
17. Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer.
Jotsuka T; Okumura Y; Nakano S; Nitta H; Sato T; Miyachi M; Suzumura K; Yamashita J
Surgery; 2004 Apr; 135(4):419-26. PubMed ID: 15041966
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
[TBL] [Abstract][Full Text] [Related]
19. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
[TBL] [Abstract][Full Text] [Related]
20. Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in peroperative period.
Ge MJ; Shi D; Wu QC; Wang M; Li LB
J Cancer Res Clin Oncol; 2006 Apr; 132(4):248-56. PubMed ID: 16320073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]